The lead applicant in a shareholder class action over Slater & Gordonâs disastrous $1.2 billion Quindell acquisition has said he might have âdumpedâ his stock before the firm experienced massive losses in 2016 if not for Pitcher Partners and Ernst & Youngâs allegedly faulty advice.
The High Court has rejected Volkswagen’s special leave application to challenge a record $125 million penalty for selling cars with a defeat device that allowed them to cheat on emissions tests.
Logistics company GetSwift says it is considering an appeal of an 859-page judgment which lambasted the company and its directors’ “public relations-driven approach” to announcements on the Australian Stock Exchange.
Accounting firms EY and Pitcher Partners ignored âfront page newsâ that Slater & Gordonâs acquired business Quindell was scrutinised by a UK regulator after reporting a $250 million (ÂŁ137 million) loss, a court heard on the second day of trial in a class action by the law firmâs shareholders.
The Sparke Helmore partner at the centre of a $1 million professional negligence lawsuit attempted to conceal an âoversight of enormous proportionsâ that is said to have lost a property developer two lucrative contracts, a court has heard.
The Banksia Securities class action saga will return to the appeals court, with a lawyer indicating he plans to challenge last month’s ruling that found he knowingly assisted in a plot to defraud tens of thousands of investors in the collapsed lender.
In rejecting a bid by The Star Entertainment Group to recoup losses stemming from the COVID-19 pandemic, the Federal Court’s Chief Justice did “real and unexplained violence” to the construction of a business interruption policy the casino giant had taken out with Chubb, the Full Court has heard.
Johnson & Johnson unit Ethicon will now be on the hook for damages to 11,000 women implanted with defective pelvic mesh devices, after the High Court declined to hear its appeal of a ruling that found it failed to adequately warn about the devices’ risks.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
The High Court has found a 15 per cent âbackpacker taxâ imposed on holders of Australian working holiday visas violates a double taxation agreement between Australia and the UK.